Literature DB >> 30192100

Serotonin, psychedelics and psychiatry.

Robin L Carhart-Harris1.   

Abstract

Entities:  

Year:  2018        PMID: 30192100      PMCID: PMC6127802          DOI: 10.1002/wps.20555

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

Review 1.  The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Authors:  Robin L Carhart-Harris; Guy M Goodwin
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

2.  Psychedelics and the essential importance of context.

Authors:  Robin L Carhart-Harris; Leor Roseman; Eline Haijen; David Erritzoe; Rosalind Watts; Igor Branchi; Mendel Kaelen
Journal:  J Psychopharmacol       Date:  2018-02-15       Impact factor: 4.153

3.  Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment.

Authors:  S Alboni; R M van Dijk; S Poggini; G Milior; M Perrotta; T Drenth; N Brunello; D P Wolfer; C Limatola; I Amrein; F Cirulli; L Maggi; I Branchi
Journal:  Mol Psychiatry       Date:  2015-09-15       Impact factor: 15.992

Review 4.  Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.

Authors:  Avshalom Caspi; Ahmad R Hariri; Andrew Holmes; Rudolf Uher; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2010-03-15       Impact factor: 18.112

5.  Activity patterns of serotonin neurons underlying cognitive flexibility.

Authors:  Sara Matias; Eran Lottem; Guillaume P Dugué; Zachary F Mainen
Journal:  Elife       Date:  2017-03-21       Impact factor: 8.140

Review 6.  Serotonin and brain function: a tale of two receptors.

Authors:  R L Carhart-Harris; D J Nutt
Journal:  J Psychopharmacol       Date:  2017-08-31       Impact factor: 4.153

Review 7.  A systematic review of comparative efficacy of treatments and controls for depression.

Authors:  Arif Khan; James Faucett; Pesach Lichtenberg; Irving Kirsch; Walter A Brown
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

8.  Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Authors:  Leor Roseman; David J Nutt; Robin L Carhart-Harris
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810

  8 in total
  9 in total

Review 1.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 2.  Aversive motivation and cognitive control.

Authors:  Debbie M Yee; Xiamin Leng; Amitai Shenhav; Todd S Braver
Journal:  Neurosci Biobehav Rev       Date:  2021-12-12       Impact factor: 8.989

Review 3.  Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes.

Authors:  Jacopo Sapienza; Marta Bosia; Marco Spangaro; Francesca Martini; Giulia Agostoni; Federica Cuoco; Federica Cocchi; Roberto Cavallaro
Journal:  Mol Psychiatry       Date:  2022-08-05       Impact factor: 13.437

Review 4.  Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System.

Authors:  Kate Z Peters; Joseph F Cheer; Raffaella Tonini
Journal:  Trends Neurosci       Date:  2021-03-03       Impact factor: 16.978

Review 5.  Psychedelic Cognition-The Unreached Frontier of Psychedelic Science.

Authors:  Maria Bălăeţ
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

6.  DMT alters cortical travelling waves.

Authors:  Andrea Alamia; Christopher Timmermann; Rufin VanRullen; Robin L Carhart-Harris; David J Nutt
Journal:  Elife       Date:  2020-10-12       Impact factor: 8.140

7.  Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Authors:  Rita Kočárová; Jiří Horáček; Robin Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-07-19       Impact factor: 4.157

8.  Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Authors:  Robin L Carhart-Harris; Anne C Wagner; Manish Agrawal; Hannes Kettner; Jerold F Rosenbaum; Adam Gazzaley; David J Nutt; David Erritzoe
Journal:  J Psychopharmacol       Date:  2021-04-22       Impact factor: 4.153

Review 9.  Pivotal mental states.

Authors:  Ari Brouwer; Robin Lester Carhart-Harris
Journal:  J Psychopharmacol       Date:  2020-11-11       Impact factor: 4.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.